Biovie Inc. SEC filings BIVIW

Biovie Inc. has 507 filings in SEC EDGAR's recent list, going back to Jul 2, 2013. Its latest annual report, Form 10-K, was filed on Aug 13, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 11, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (material agreement). The company's fiscal year ends on June 30.

Form Description Filed Period
10-K Annual report Aug 13, 2026 Jun 30, 2026
10-K Annual report Aug 15, 2025 Jun 30, 2025
10-K Annual report Sep 30, 2024 Jun 30, 2024
10-K Annual report Aug 16, 2023 Jun 30, 2023
10-K Annual report Sep 27, 2022 Jun 30, 2022
10-K Annual report Aug 30, 2021 Jun 30, 2021
10-K/A Amended annual report Aug 7, 2020 Jun 30, 2020
10-K Annual report Aug 6, 2020 Jun 30, 2020
10-K Annual report Sep 27, 2019 Jun 30, 2019
10-K Annual report Oct 5, 2018 Jun 30, 2018
10-K Annual report Aug 24, 2017 Jun 30, 2017
10-K Annual report Sep 28, 2016 Jun 30, 2016
10-K Annual report Oct 1, 2015 Jun 30, 2015
10-K Annual report Sep 24, 2014 Jun 30, 2014

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BIVI (Nasdaq), BIVIW (Nasdaq)
Fiscal year ends
June 30
Incorporated in
NV
Headquarters
Carson City, NV
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1580149
Former names
NANOANTIBIOTICS, INC. (until Jul 22, 2016)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.